Changes in the Epidemiology of Respiratory Pathogens in Children during the COVID-19 Pandemic

Asmae Lamrani Hanchi1, Morad Guennouni2, Toufik Ben Houmich1

  • 1Laboratory of Microbiology, University Hospital Mohamed VI, Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech 40030, Morocco.

Insights

COVID-19 pandemic measures significantly reduced non-COVID-19 respiratory illnesses in children. Respiratory Syncytial Virus and Influenza A detections notably decreased, while Human Rhinovirus remained prevalent.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Epidemiology

Background:

  • The COVID-19 pandemic prompted public health interventions impacting respiratory pathogen transmission.
  • Observed decreases in non-COVID-19 respiratory illnesses suggest broader epidemiological effects.

Purpose of the Study:

  • To investigate changes in the epidemiology of pediatric respiratory pathogens during the COVID-19 pandemic.
  • To analyze the impact of COVID-19 preventive measures on the circulation of common respiratory viruses in children.

Main Methods:

  • Retrospective analysis of 902 pediatric severe acute respiratory illness cases (January 2018-December 2021).
  • Respiratory pathogen detection using the Film Array Respiratory Panel for patients with negative COVID-19 PCR tests.
  • Statistical analysis to compare pathogen prevalence between pre-pandemic and pandemic periods.

Main Results:

  • Overall lower respiratory pathogen positivity rates observed during the COVID-19 pandemic (p = 0.006), particularly in infants under 6 months (p = 0.008).
  • Significant reduction in Respiratory Syncytial Virus and Influenza A detection during the first winter post-pandemic outbreak (p < 0.05; p = 0.002).
  • Human Rhinovirus showed year-round prevalence, with increased winter detection during the pandemic (p = 0.0002).

Conclusions:

  • COVID-19 preventive measures substantially altered pediatric respiratory pathogen epidemiology.
  • The study highlights the significant impact of non-pharmaceutical interventions on the transmission dynamics of various respiratory viruses in children.

Related Concept Videos

Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
790
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
300
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
414
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.3K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
429
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.7K